Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
13,227,514
-
Total 13F shares
-
182,551
-
Share change
-
-155,248
-
Total reported value
-
$161,999
-
Price per share
-
$0.8900
-
Number of holders
-
14
-
Value change
-
-$141,059
-
Number of buys
-
7
-
Number of sells
-
5
Institutional Holders of Silo Pharma, Inc. - Common stock, par value $0.0001 per share (SILO) as of Q4 2024
As of 31 Dec 2024 Silo Pharma, Inc. - Common stock, par value $0.0001 per share (SILO) had 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 182,551 shares of stock of the company.
Largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, VANGUARD GROUP INC, XTX Topco Ltd, STATE STREET CORP, HRT FINANCIAL LP, TWO SIGMA SECURITIES, LLC, Virtu Financial LLC, and Federation des caisses Desjardins du Quebec.
This table shows 14 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.